Inactive Instrument

News Regenicin, Inc. Other OTC

Equities

RGIN

US75887Q1022

Summary

Unlock all the news: Be the first to know and act before the market!

Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	16/23/16	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/23/14	AQ
Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	14/23/14	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	14/23/14	AQ
Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	14/23/14	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	13/22/13	AQ
Regenicin, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	13/22/13	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/22/23	AQ
Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	23/22/23	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	26/22/26	AQ
REGENICIN, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	26/22/26	AQ
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	15/22/15	AQ
Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	15/22/15	CI
REGENICIN, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	09/22/09	AQ
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	13/22/13	AQ
Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	13/22/13	CI
REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/21/23	AQ
Regenicin, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	23/21/23	CI
REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	18/21/18	AQ
Regenicin, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	18/21/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Regenicin, Inc. Other OTC

Equities

RGIN

US75887Q1022

Summary

Filters